You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Sutter Hill Ventures, a California Limited Partnership | 296,614 | 0 | 296,614 | 0 | 296,614 | 3.3% |
William H. Younger, Jr | 100,782 | 296,614 | 100,782 | 296,614 | 397,396 | 4.5% |
Tench Coxe | 70,711 | 296,614 | 70,711 | 296,614 | 367,325 | 4.1% |
James N. White | 22,494 | 296,614 | 22,494 | 296,614 | 319,108 | 3.6% |
Jeffrey W. Bird | 20,610 | 296,614 | 20,610 | 296,614 | 317,224 | 3.6% |
Michael L. Speiser | 21,947 | 296,614 | 21,947 | 296,614 | 318,561 | 3.6% |
Stefan A. Dyckerhoff | 4,264 | 296,614 | 4,264 | 296,614 | 300,878 | 3.4% |
Samuel J. Pullara III | 4,264 | 296,614 | 4,264 | 296,614 | 300,878 | 3.4% |
Page 1 of 14 SEC Filing
UNITED STATES | ||
SECURITIES AND EXCHANGE COMMISSION | ||
Washington, D.C. 20549 | ||
SCHEDULE 13D |
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Page 2 of 14 SEC Filing
CUSIP No. 14141R309 | |||||
1. | Names of Reporting Persons Sutter Hill Ventures, a California Limited Partnership | ||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) | ||||
(a) | o | ||||
(b) | x | ||||
3. | SEC Use Only | ||||
4. | Source of Funds (See Instructions) WC | ||||
5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | ||||
6. | Citizenship or Place of Organization California | ||||
Number of Shares Beneficially Owned by Each Reporting Person With | 7. | Sole Voting Power 296,614* | |||
8. | Shared Voting Power 0 | ||||
9. | Sole Dispositive Power 296,614* | ||||
10. | Shared Dispositive Power 0 | ||||
11. | Aggregate Amount Beneficially Owned by Each Reporting Person 296,614 | ||||
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | ||||
13. | Percent of Class Represented by Amount in Row (11) 3.3% | ||||
14. | Type of Reporting Person (See Instructions) PN |
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Page 3 of 14 SEC Filing
CUSIP No. 14141R309 | |||||
1. | Names of Reporting Persons William H. Younger, Jr. | ||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) | ||||
(a) | o | ||||
(b) | x | ||||
3. | SEC Use Only | ||||
4. | Source of Funds (See Instructions) PF | ||||
5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | ||||
6. | Citizenship or Place of Organization United States | ||||
Number of Shares Beneficially Owned by Each Reporting Person With | 7. | Sole Voting Power 100,782* | |||
8. | Shared Voting Power 296,614** | ||||
9. | Sole Dispositive Power 100,782* | ||||
10. | Shared Dispositive Power 296,614** | ||||
11. | Aggregate Amount Beneficially Owned by Each Reporting Person 397,396 | ||||
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | ||||
13. | Percent of Class Represented by Amount in Row (11) 4.5% | ||||
14. | Type of Reporting Person (See Instructions) IN |
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Page 4 of 14 SEC Filing
CUSIP No. 14141R309 | |||||
1. | Names of Reporting Persons Tench Coxe | ||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) | ||||
(a) | o | ||||
(b) | x | ||||
3. | SEC Use Only | ||||
4. | Source of Funds (See Instructions) PF | ||||
5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | ||||
6. | Citizenship or Place of Organization United States | ||||
Number of Shares Beneficially Owned by Each Reporting Person With | 7. | Sole Voting Power 70,711* | |||
8. | Shared Voting Power 296,614** | ||||
9. | Sole Dispositive Power 70,711* | ||||
10. | Shared Dispositive Power 296,614** | ||||
11. | Aggregate Amount Beneficially Owned by Each Reporting Person 367,325 | ||||
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | ||||
13. | Percent of Class Represented by Amount in Row (11) 4.1% | ||||
14. | Type of Reporting Person (See Instructions) IN |
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Page 5 of 14 SEC Filing
CUSIP No. 14141R309 | |||||
1. | Names of Reporting Persons James N. White | ||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) | ||||
(a) | o | ||||
(b) | x | ||||
3. | SEC Use Only | ||||
4. | Source of Funds (See Instructions) PF | ||||
5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | ||||
6. | Citizenship or Place of Organization United States | ||||
Number of Shares Beneficially Owned by Each Reporting Person With | 7. | Sole Voting Power 22,494* | |||
8. | Shared Voting Power 296,614** | ||||
9. | Sole Dispositive Power 22,494* | ||||
10. | Shared Dispositive Power 296,614** | ||||
11. | Aggregate Amount Beneficially Owned by Each Reporting Person 319,108 | ||||
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | ||||
13. | Percent of Class Represented by Amount in Row (11) 3.6% | ||||
14. | Type of Reporting Person (See Instructions) IN |
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Page 6 of 14 SEC Filing
CUSIP No. 14141R309 | |||||
1. | Names of Reporting Persons Jeffrey W. Bird | ||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) | ||||
(a) | o | ||||
(b) | x | ||||
3. | SEC Use Only | ||||
4. | Source of Funds (See Instructions) PF | ||||
5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | ||||
6. | Citizenship or Place of Organization United States | ||||
Number of Shares Beneficially Owned by Each Reporting Person With | 7. | Sole Voting Power 20,610* | |||
8. | Shared Voting Power 296,614** | ||||
9. | Sole Dispositive Power 20,610* | ||||
10. | Shared Dispositive Power 296,614** | ||||
11. | Aggregate Amount Beneficially Owned by Each Reporting Person 317,224 | ||||
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | ||||
13. | Percent of Class Represented by Amount in Row (11) 3.6% | ||||
14. | Type of Reporting Person (See Instructions) IN |
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Page 7 of 14 SEC Filing
CUSIP No. 14141R309 | |||||
1. | Names of Reporting Persons Michael L. Speiser | ||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) | ||||
(a) | o | ||||
(b) | x | ||||
3. | SEC Use Only | ||||
4. | Source of Funds (See Instructions) PF | ||||
5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | ||||
6. | Citizenship or Place of Organization United States | ||||
Number of Shares Beneficially Owned by Each Reporting Person With | 7. | Sole Voting Power 21,947* | |||
8. | Shared Voting Power 296,614** | ||||
9. | Sole Dispositive Power 21,947* | ||||
10. | Shared Dispositive Power 296,614** | ||||
11. | Aggregate Amount Beneficially Owned by Each Reporting Person 318,561 | ||||
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | ||||
13. | Percent of Class Represented by Amount in Row (11) 3.6% | ||||
14. | Type of Reporting Person (See Instructions) IN |
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Page 8 of 14 SEC Filing
CUSIP No. 14141R309 | |||||
1. | Names of Reporting Persons Stefan A. Dyckerhoff | ||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) | ||||
(a) | o | ||||
(b) | x | ||||
3. | SEC Use Only | ||||
4. | Source of Funds (See Instructions) PF | ||||
5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | ||||
6. | Citizenship or Place of Organization German citizen (U.S. permanent resident) | ||||
Number of Shares Beneficially Owned by Each Reporting Person With | 7. | Sole Voting Power 4,264* | |||
8. | Shared Voting Power 296,614** | ||||
9. | Sole Dispositive Power 4,264* | ||||
10. | Shared Dispositive Power 296,614** | ||||
11. | Aggregate Amount Beneficially Owned by Each Reporting Person 300,878 | ||||
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | ||||
13. | Percent of Class Represented by Amount in Row (11) 3.4% | ||||
14. | Type of Reporting Person (See Instructions) IN |
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Page 9 of 14 SEC Filing
CUSIP No. 14141R309 | |||||
1. | Names of Reporting Persons Samuel J. Pullara III | ||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) | ||||
(a) | o | ||||
(b) | x | ||||
3. | SEC Use Only | ||||
4. | Source of Funds (See Instructions) PF | ||||
5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | ||||
6. | Citizenship or Place of Organization United States | ||||
Number of Shares Beneficially Owned by Each Reporting Person With | 7. | Sole Voting Power 4,264* | |||
8. | Shared Voting Power 296,614** | ||||
9. | Sole Dispositive Power 4,264* | ||||
10. | Shared Dispositive Power 296,614** | ||||
11. | Aggregate Amount Beneficially Owned by Each Reporting Person 300,878 | ||||
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | ||||
13. | Percent of Class Represented by Amount in Row (11) 3.4% | ||||
14. | Type of Reporting Person (See Instructions) IN |
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Page 10 of 14 SEC Filing
Explanatory Note: This Schedule 13D/A (the “Schedule 13D/A”) is being filed by the Reporting Persons (as defined below) to amend the Schedule 13D originally filed with the Securities and Exchange Commission (the “Commission”) on March 29, 2013 (the “Original Schedule 13D”) to report the distribution of shares of Common Stock of the Issuer by SHV (as defined below) to the managing members of its general partner in accordance with the terms of its partnership agreement. The Original Schedule 13D is hereby amended and supplemented as detailed below, and, except as specifically amended and supplemented hereby, the Original Schedule 13D remains in full force and effect. The share ownership reported herein gives effect to a one-for-ten reverse stock split of the Issuer’s Common Stock effected on February 17, 2016. | ||
Item 2. | Identity and Background | |
Item 2 of the Original Schedule 13D is hereby amended and restated in its entirety as follows: | ||
(a) | This Schedule is filed by Sutter Hill Ventures, a California Limited Partnership (“SHV”), William H. Younger, Jr., Tench Coxe, James N. White, Jeffrey W. Bird, Michael L. Speiser, Stefan A. Dyckerhoff and Samuel J. Pullara III (collectively, the “Reporting Persons”). | |
(b) | The business address for each of the Reporting Persons is 755 Page Mill Rd., Suite A-200, Palo Alto, CA 94304. | |
(c) | SHV’s principal business is venture capital investing. The other Reporting Persons’ present principal occupation or employment is serving as a managing director of the general partner of SHV. The principal business address of the organization in which such employment is conducted is 755 Page Mill Rd., Suite A-200, Palo Alto, CA 94304. | |
(d) | and (e) None of the Reporting Persons have, during the past five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). None of the Reporting Persons have, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. | |
(f) | SHV is a California limited partnership. Each of the other Reporting Persons is a U.S. citizen except Mr. Dyckerhoff who is a German citizen and U.S. permanent resident. | |
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Page 11 of 14 SEC Filing
Item 4. | Purpose of Transaction |
Item 4 of the Original Schedule 13D is hereby amended and supplemented by adding the following at the end thereof: On February 26, 2016, in accordance with the terms of the its partnership agreement, SHV distributed 44,665 shares of the Issuer’s Common Stock to the managing directors of its general partner. | |
Item 5. | Interest in Securities of the Issuer |
Item 5 of the Original Schedule 13D is hereby amended and restated in its entirety as follows: (a) — (b) The responses to Nos. 7 — 13 of the several cover pages of the Schedule are incorporated herein by reference. Additionally, the information included in Appendix A hereto is also incorporated herein by reference. | |
(c) As a result of the distribution by SHV on February 26, 2016, the following Reporting Persons received the following shares: |
Reporting Person | | Number of Shares Received in Distribution | ||
William H. Younger, Jr. | | 56 | | |
Tench Coxe | | 2,654 | | |
James N. White | | 6,084 | | |
Jeffrey W. Bird | | 6,948 | | |
Michael L. Speiser | 21,099 | |||
Stefan A. Dyckerhoff | | 2,421 | | |
Samuel J. Pullara III | 2,421 |
Except as set forth above, none of the Reporting Persons has effected any transactions in the Common Stock during the past 60 days. | |
(d) The Reporting Persons know of no other person having the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares beneficially owned by the Reporting Persons. | |
(e) As of February 26, 2016, the Reporting Persons no longer beneficially owned 5% of the Issuer’s outstanding Common Stock. | |
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Page 12 of 14 SEC Filing
March 1, 2016 | SUTTER HILL VENTURES, A CALIFORNIA LIMITED | ||
Date | PARTNERSHIP | ||
By: | /s/ Robert Yin | ||
Robert Yin, Attorney-in-Fact for William H. Younger, Jr., managing director of the general partner | |||
By: | /s/ Robert Yin | ||
Robert Yin, Attorney-in-Fact for William H. Younger, Jr. | |||
By: | /s/ Robert Yin | ||
| Robert Yin, Attorney-in-Fact for Tench Coxe | ||
By: | /s/ Robert Yin | ||
| Robert Yin, Attorney-in-Fact for James N. White | ||
By: | /s/ Robert Yin | ||
| Robert Yin, Attorney-in-Fact for Jeffrey W. Bird | ||
By: | /s/ Robert Yin | ||
| Robert Yin, Attorney-in-Fact for Michael L. Speiser | ||
By: | /s/ Robert Yin | ||
| Robert Yin, Attorney-in-Fact for Stefan A. Dyckerhoff | ||
By: | /s/ Robert Yin | ||
Robert Yin, Attorney-in-Fact for Samuel J. Pullara III |
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Follow Dextera Surgical Inc (NASDAQ:DXTR)
Page 13 of 14 SEC Filing
Aggregate Number of | |||||||||||
Shares Beneficially Owned | % of | ||||||||||
Name of Originator | Individual | Aggregate | Total Shares | ||||||||
Sutter Hill Ventures, a California Limited Partnership | 296,614 | Note 1 | 3.3 | % | |||||||
William H. Younger, Jr. | 100,782 | Note 3 | 1.1 | % | |||||||
397,396 | Note 2 | 4.5 | % | ||||||||
Tench Coxe | 70,711 | Note 4 | 0.8 | % | |||||||
367,325 | Note 2 | 4.1 | % | ||||||||
James N. White | 22,494 | Note 5 | 0.3 | % | |||||||
319,108 | Note 2 | 3.6 | % | ||||||||
Jeffrey W. Bird | 20,610 | Note 6 | 0.2 | % | |||||||
317,224 | Note 2 | 3.6 | % | ||||||||
Michael L. Speiser | 21,947 | Note 7 | 0.2 | % | |||||||
318,561 | Note 2 | 3.6 | % | ||||||||
Stefan A. Dyckerhoff | 4,264 | Note 8 | 0.0 | % | |||||||
300,878 | Note 2 | 3.4 | % | ||||||||
Samuel J. Pullara III | 4,264 | Note 9 | 0.0 | % | |||||||
300,878 | Note 2 | 3.4 | % |